Introduction {#s1}
============

Coral reefs are one of the most productive and diversified ecosystems on the planet (Connell, [@B16]) and they provide a wealth of ecological services as well as being economically important, supporting fisheries, tourism, and medical applications (Moberg and Folke, [@B46]; Hughes et al., [@B35]; Cooper et al., [@B17]). The health of these ecosystems is severely threatened by the combined effect of local anthropogenic pressures and global changes (Jackson et al., [@B36]; Hughes et al., [@B35]; Pandolfi et al., [@B50]; Bellwood et al., [@B4]). Over-exploitation of marine species, pollution, and increased sea surface temperature are associated with the emergence of coral diseases, which are contributing to the decline of coral reefs worldwide.

Several studies have identified *Vibrio* spp. (⋎-Proteobacteria*)* as causative agents of coral bleaching for multiple coral species and in multiple locations (Ushijima et al., [@B61]; reviewed in Mera and Bourne, [@B44]). *Vibrio coralliilyticus* (*V. coralliilyticus*) has emeregd as an important bacterial pathogen model for understanding the establishement and propagation of coral disease (Sussman et al., [@B58]; O\'Santos et al., [@B48]; Garren et al., [@B27]; Pollock et al., [@B51]). Studies have shown that V. *coralliilyticus* infection is temperature dependent and infects the coral endosymbiont *Symbiodinum* through the production of proteases that inhibit photosynthesis. This results in the loss of the endosymbiont from the coral tissues and ultimately leads to coral bleaching (Ben-Haim et al., [@B5]; Sussman et al., [@B58], [@B57]; Cohen et al., [@B15]). With the increasing devastation of coral reefs, the development of new tools and strategies to control pathogens and treat diseased corals is becoming a major issue. Currently, biocontrol strategies, such as phage therapy, are being seriously evaluated for mitigating coral diseases (Efrony et al., [@B24]; Teplitski and Ritchie, [@B60]; Atad et al., [@B2]; Cohen et al., [@B15]).

The potential of viruses (more specifically bacteria viruses also referred to as bacteriophages or phages) as therapeutic agents to treat infectious diseases has been known for a long time (d\'Herelle, [@B20]; Duckworth, [@B22]; Duckworth and Gulig, [@B23]). The idea of phage therapy arose from the early discovery that a given virus usually infects a single host species, leaving the rest of the microbial community untouched. Moreover, viruses are obligate intracellular organisms and, therefore, their production is self-regulated and limited by the availability of suitable hosts. Over the past decade, there have been promising *in vitro* and *in situ* trials of phage therapy for corals. One used BA3, a virulent bacteriophage that infect the causative agent of white plague disease (Efrony et al., [@B25], [@B24]), to inhibit the progression of the disease and its transmission to healthy corals (Atad et al., [@B2]). Although this research is still at an early stage, this promising result in the open sea suggest that *in situ* phage therapy for coral diseases is achievable (Atad et al., [@B2]). The isolation and characterization of new bacteriophages is, therefore, essential to increase the collection of potential candidates for therapeutic assays.

The therapeutic value of a candidate bacteriophage relies on the characterization of viral properties such as the virion stability, growth kinetics, viral yield, and host range. Understanding the lifestyle of the candidate phage is probably the key to their use in therapy. Only virulent bacteriophages, which replicate through a lytic cycle and kill their host after infection, will be suitable candidates. Temperate bacteriophages, which replicate using a lysogenic cycle, may improve host fitness through gene transfer. It is, however, difficult to distinguish between virulent and temperate phage because temperate viruses can switch to a lytic cycle in response to environmental changes, such as temperature, pH salinity, UV, pollution, or nutrient availability (Jiang and Paul, [@B37]; Williamson and Paul, [@B63], reviewed in Howard-Varona et al., [@B34]). Furthermore, infection dynamics can be highly variable, even between two closely related hosts (Holmfeld et al., [@B33]; Dang et al., [@B18]). Over the past decade, genomics has greatly improved our understanding of host---virus interactions, and is the key to establishing whether a candidate is an obligate lytic bacteriophage (Howard-Varona et al., [@B34]). Bacteriophage genome sequencing is also essential for evaluating the safety of a candidate (absence of toxins and temperate phage hallmarks), and to provide information on the candidate\'s evolution history and ecology (Lobocka et al., [@B42]).

In this study, we report a novel bacteriophage, hereafter referred to as *Vibrio* phage BONAISHI that infects the model coral pathogen *V. coralliilyticus*. We studied it using a combination of functional, genomic, and metagenomic approaches to evaluate the potential of this phage for mitigating disease caused by *V. coralliilyticus*.

Material and methods {#s2}
====================

Virus isolation
---------------

Seawater samples were collected from coral surrounding water off Whale Island (Van Phong Bay, Vietnam). A 50 mL aliquot was supplemented with 10% (v/v) Marine Broth (MB, Difco) and the mixture was enriched with 1 mL *Vibrio coralliilyticus* LMG20984 (YB1) culture and incubated for 48 h at 25°C (Brussaard et al., [@B9]). The sample was clarified (7,000 g, 15 min) and the supernatant was filtered through 0.2 μm PES filters to separate the viral community. A 100 μL aliquot of the filtrate was added to 900 μL YB1 culture and incubated for 30 min at 25°C. The mixture was included in molten agar (Marine Broth supplemented with 0.6% noble agar) and spread on a Marine Agar plate. After 48 h incubation, a translucent plaque indicating host lysis was removed from the bacterial lawn, eluted in 0.22 μm filtered Salt Marine (SM) buffer (100 mM NaCl, 8 mM MgSO4, 50 mM Tris-HCl pH 8.0) and combined with a host culture in a plaque assay (Brussaard et al., [@B9]). This procedure was repeated twice to ensure the clonality of the bacteriophage. Finally, the clonal phage suspension and host culture were used in a plaque assay giving confluent lysis. The plaques were eluted in SM buffer, the eluent was clarified by centrifugation (7,000 g, 30 min, 4°C), and the supernatant was filtered through 0.22 μm and stored at 4°C until use.

Transmission electronic microscopy
----------------------------------

A 10 μL aliquot of the phage suspension was loaded onto a Formvar/carbon film coated 400 mesh copper grid (Euromedex). After 5 min incubation, the grid was blotted with filter paper and stained with 2% uranyl acetate for 30 s, blotted again to remove excess dye and air dried for 30 min (Ackermann and Heldal, [@B1]). The specimen was imaged using JEOL 1400 transmission electron microscope operating at 120 keV at a magnification of 80,000X.

Environmental range of infectivity
----------------------------------

The tolerance of BONAISHI to temperature and pH ranges was evaluated by monitoring the loss of infectivity of a freshly produced suspension by spot test. For evaluating the temperature range, 100 μL of viral suspension (5 x 10^8^ PFU/mL) was incubated at temperatures from 4 to 70°C for 30 min in a dry bath. The samples were then cooled for 5 min at 4°C and virus infectivity was assessed by spot test. Briefly, 5 μL of the treated viral suspension was spotted on a host lawn obtained by plating a 1:4 mixture of host culture in molten agar onto a marine agar plate. For evaluating the pH range, 100 μL of viral suspension were added to 900 μL SM buffer adjusted at pH ranging from 2 to 10. The samples were incubated for 24 h at 4°C and then spot-tested as described above.

Host range
----------

A selection of 43 bacterial strains (Table [S1](#SM1){ref-type="supplementary-material"}) related to the original host *V. coralliilyticus* YB1 were used to determine the host specificities of BONAISHI. The ability of BONAISHI phage to infect these strains was determined by pairwise infection. The bacterial strains were grown in Marine Broth media (DIFCO) overnight. Each culture was included in molten agar (Marine Broth supplemented with 0.6% noble agar) and spread on a Marine Agar plate. A freshly produced suspension of BONAISHI was serially diluted in SM buffer and a 5 μL drop of each dilution was spotted on a bacterial lawn. After 24--48h incubation at 25°C, the formation of translucent spots, indicative of host lysis, was recorded.

Life strategy
-------------

The growth cycle of BONAISHI was tested on two *V. coralliilyticus* strains including the original host LMG 20984 (YB1) and the alternate host LMG 23696 (P1) (Middelboe et al., [@B45]). Both host cultures were grown in MB and divided into four 25 mL sub-cultures. One sub-culture served as control and the remaining 3 were inoculated with a freshly produced BONAISHI suspension at multiplicity of infection (MOI) of 0.1 as determined by flow cytometry (see below). All cultures were incubated at 25°C for 48 h. Samples for viral and bacterial counts were taken every hour for 10 h, and then every 4 h for 48 h. Samples were immediately fixed with glutaraldehyde (0.5% final concentration) for 10 min at 4°C, flash frozen in liquid nitrogen, and stored at −80°C until flow cytometry analysis (see below). Bacterial host and virus counts were used to calculate the phage latent period and burst size. The latent period corresponds to the time elapsed between the viral inoculation and the release of virions. The burst-size, which corresponds to the number of virions produced per infected host cell, was determined by the ratio of the net increase in virus concentration over the net decrease in host concentration during the first burst.

Flow cytometry
--------------

For determining the bacterial abundance, samples were diluted in autoclaved 0.2 μm filtered TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and stained with a SYBR Green (10,000-fold dilution of commercial solution) for 15 min in the dark at ambient temperature. For determining the viral abundance, 100--1,000-fold diluted samples were stained with SYBR Green (20,000-fold dilution of commercial solution) for 10 min in the dark at 80°C. Analyses were performed using a FACS Canto II equipped with an argon-laser (455 nm). The trigger was set on the green fluorescence and the sample was delivered at a rate of 0.06 mL min^−1^ and analyzed for 1 min (Brussaard, [@B8]). Viral and bacterial counts were corrected for a blank consisting of TE-buffer with autoclaved 0.2 μm filtered seawater at the corresponding dilution.

Genome extraction and sequencing
--------------------------------

A 1 L viral suspension was concentrated by ultrafiltration using a 30 kDa PES membrane (Vivaflow 50, Vivascience) and centrifugal concentrator (Vivaspin 20, 30 kDa, PES) to a final volume of 2 mL. The concentrate was subsequently purified on linear sucrose gradient (10--40 % in 0.2 μm SM) by ultracentrifugation (SW41.Ti rotor, 96,808 g, 30 min at 4°C). The BONAISHI particles formed a well resolved band that was extracted, dialyzed against SM buffer using a centrifugal concentrator (Vivaspin 20, 30 kDa, PES) and stored at 4°C until use. The genome of the purified phage suspension was extracted using a DNAeasy Blood and Tissue kit (QUIAGEN, Valencia, CA) according to the manufacturer\'s protocol. Samples were sent to GATC Biotech, and sequenced using PACBIO RS II (17,131 mean read length). Raw read sequences assembled as a single contig using HGAP software (Chin et al., [@B13]). The final draft assembly was 303, 340 bp with an average coverage of 1,720x and an average base quality score of 86%.

Bioinformatic analysis
----------------------

### Phage genome annotation

Putative coding DNA sequences (CDS) in the BONAISHI genome were predicted using Glimmer (Delcher et al., [@B19]) and Genemark (Besemer et al., [@B6]). The coordinates of each translated open reading frames (ORF) were also inspected manually. ORF smaller than 200 base pairs (bp) were removed from the analysis. The predicted amino acid sequences were assigned manually by BLASTP and PSI-BLAST (cutoff e-value \< 10^−5^) against the NCBI non-redundant database (January 2018) and InterProScan 5 (Jones et al., [@B38]), as well as the fully automated RAST server annotation service (Aziz et al., [@B3]). BLASTP was used to search for putative toxins in the databases MvirDB (Zhou et al., [@B68]), VirulenceFinder (Chen et al., [@B12]), Vibrio-base (Choo et al., [@B14]), and t3DB (Lim et al., [@B41]; Wishart et al., [@B64]) toxin databases. The IntegrallDB (Moura et al., [@B47]) and ACLAME (Leplae et al., [@B40]) databases were used to check for prophage-like sequences. tRNAScanSE (Lowe and Eddy, [@B43]) and Aragorn (Laslett and Canback, [@B39]) were used to check for tRNA. The genome map was produced using Artemis (Rutherford et al., [@B55]) and DNA Plotter (Carver et al., [@B10]). The BONAISHI genome sequence has been submitted to the GenBank database under accession number [MH595538](MH595538).

### Terminase large subunit (TerL) protein phylogeny

The amino acids sequence of the terminase large subunit from 63 jumbo phages including BONAISHI were used for phylogenetic analysis. Sequences were trimmed to 406 bp, the minimum sequence length of *Aeromonas* phage px29, using BioEdit (Hall, [@B31]). Sequences were aligned by Muscle and the tree was constructed by Maximum Likelihood with 1,000 bootstrap iterations using Mega 6.06 (Tamura et al., [@B59]).

### Host genome analysis

The clustered regularly interspaced short palindromic repeats (CRISPR), in the pathogenic *V. coralliilyticus* strains P1 and YB1 genome, were searched for genetic signatures of viral resistance mechanisms using CRISPRfinder (Grissa et al., [@B29]). Genetic exchange between the phage BONAISHI and its bacterial hosts was checked by homology between the phage ORFs and the ORFs of *V. coralliilyticus* P1 (AEQS00000000) and YB1 (ACZN00000000) using BLASTP.

### Metagenomic analysis

To determine the distribution of BONAISHI, the genome was used to recruit homologous reads from 56 coral-associated virome in Metavir (Roux et al., [@B54]), and 137 CAMERA Broad Phage metagenomes (Seshadri et al., [@B56]) and viral contigs in IMG/VR (Paez-Espino et al., [@B49], Table [S2](#SM2){ref-type="supplementary-material"}). These samples comprised a wide range of marine environments including tropical and temperate pelagic ecosystems, healthy and diseased coral reefs including slurry from individual coral colonies, coral mucus, and the water from coral reefs. We also carried out recruitments in prokaryote metagenome from 4 coral atolls (Dinsdale et al., [@B21]) to check whether BONAISHI genome sequences were inserted into prokaryote genomes. Each reads served as a query and was assigned to a (single) best-matching hit by BLASTN and TBLASTX if the alignments met the following criteria: e-value \< 10^−3^, alignment length \> 50, bitscore \> 40. BLASTN parameters were set to: open gap cost = 8, extend gap cost = 6, match reward = 5, mismatch penalty = −4, word size = 8. Reads were recruited from each metagenome in order to determine the fraction of recruited reads that can be assigned to BONAISHI.

Preliminary treatment of diseased symbiodinium
----------------------------------------------

Culture of *Symbiodinium* sp. cells (Clade A1) originally extracted from the scleractinian coral *Galaxea fascicularis* (Goiran et al., [@B28]) were maintained in the laboratory in F/2 medium (Guillard and Ryther, [@B30]) prepared from Guillard\'s Marine Water Enrichment Solution (Sigma-Aldrich G9903). Cultures were maintained at 25°C under 100 μmol photons m^−2^ s^−1^ of white light provided by fluorescent tubes (Mazda 18WJr/865) using a 12:12 light:dark cycle. One day prior to the therapy assay, exponentially growing *Symbiodinium* sp. cultures were transferred to 30°C under the same light conditions. A 20 mL aliquot was concentrated at 5,000 g for 10 min at 30°C (VIVASPIN 20, PES, 30 kDa). The retentate was gently resuspended in 20 ml EDTA free F/2 medium and the procedure was repeated twice to wash the culture. The *Symbiodinium sp*. abundance was determined by flow cytometry and adjusted to 10^4^ cells mL^−1^. *V. coralliilyticus YB1* was cultured overnight in MB and then purified in the same way. Bacterial abundance was determined by flow cytometry and adjusted to 10^7^ cells mL^−1^. A freshly produced suspension of BONAISHI was purified by sucrose gradient and diluted in SM buffer. The viral abundance was determined by flow cytometry.

For the therapy assay, the algal culture was split into 3 equal sub-cultures. One sub-culture served as control, while two of the subcultures were inoculated with an equal volume of *V. coralliilyticus YB1*. Of these, one was also inoculated with 10^8^ phages mL^−1^. All three treatments were sampled at 0, 5, 20, and 60 min to determine the photosystem II quantum yield of *Symbiodinium* sp. cells using a pulse amplitude modulated fluorimeter (Phyto-PAM, Walz) connected to a chart recorder (Labpro, Vernier). After 5 min relaxation in darkness, the non-actinic modulated light (450 nm) was turned on in order to measure the fluorescence basal level, F~0~. A saturating red light pulse (655 nm, 4 000 μmol quanta m^−2^ s^−1^, 400 ms) was applied to determine the maximum fluorescence level in the dark adapted sample, F~M~. The maximal photosystem II fluorescence quantum yield of photochemical energy conversion, F~V~/F~M~, was calculated using the following formula:
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Results {#s3}
=======

Morphology
----------

The *Vibrio* phage BONAISHI formed relatively large, round plaques on *V. coralliilyticus YB1* and produced high titer suspension. TEM microscopy showed that BONAISHI has an isometric capsid of 120 nm in diameter connected to a 190 nm long, contractile tail (Figure [1](#F1){ref-type="fig"}). This indicates that BONAISHI belongs to the order of the *Caudovirales* and the family of the *Myoviridae*.

![Morphology of Vibrio phage BONAISHI. **(A)** BONAISHI forms large, round plaque on a lawn of *V. coralliilyticus YB1 on* 0.6% soft agar. **(B)** Transmission electron micrographs of a negatively stained particle of bacteriophage BONAISHI. The icosahedral head (120 nm in diameter) and the long, contractile tail (190 nm in length) suggest that BONAISHI belongs to the *Myoviridae* family.](fmicb-09-02501-g0001){#F1}

Tolerance to environmental factors
----------------------------------

The incubations showed that BONAISHI can tolerate a pH ranging from 3 to 10 and temperatures ranging from 4 to 50°C without loss of infectivity (Table [1](#T1){ref-type="table"}). This high tolerance suggests that the phage is very stable in the environment.

###### 

Tolerance of *Vibrio* phage BONAISHI to temperature and pH.

  **Treatments**             **Infectivity**
  -------------------------- -----------------
  **TEMPERATURE (**°**C)**   
  4                          \+
  15                         \+
  20                         \+
  25                         \+
  30                         \+
  35                         \+
  40                         \+
  45                         \+
  50                         \+
  60                         \-
  70                         \-
  **pH**                     
  2                          \-
  3                          \+
  4                          \+
  5                          \+
  6                          \+
  7                          \+
  8                          \+
  9                          \+
  10                         \+

Host specificities
------------------

Spot tests using a broad range of potential hosts indicated that BONAISHI was able to infect and lyse several strains of *V. coralliilyticus* of interest (Table [S1](#SM1){ref-type="supplementary-material"}). Besides *V. coralliilyticus* YB1, BONAISHI can infect another known coral pathogen, *V. coralliilyticus* P1, as well as *V. coralliilyticus* LMG21348, isolated from a bleached coral colony (*Pocillopora damicornis*), and *V. coralliilyticus* 1H13, isolated from the mucus of a *Fungia* specimen. This phage did not lyse of any of the closely related species in the test, suggesting that it is species-specific.

Life cycle
----------

One-step growth experiments showed that the phage readily propagated on each of its hosts with a latent period of 2--3 h (strains P1 and YB1) and burst size of 8 (P1) and 19 (YB1) (Figure [2](#F2){ref-type="fig"}). Nearly all the virions produced (96%) were infectious virions per infected cell. The infected host culture collapsed rapidly and there was total lysis 10 h after inoculation.

![One-step growth experiments of BONAISHI on *Vibrio coralliilyticus* strain P1 **(A,B)** and YB1 **(C,D)**. Bacteria and bacteriophage counts were assessed by flow cytometry upon staining with the nucleic acid dye SYBR Green (Life technology) according to Brussaard ([@B8]).](fmicb-09-02501-g0002){#F2}

General features of BONAISHI genome
-----------------------------------

The genome of BONAISHI consists of a large double-stranded circularly permuted DNA sequence of 303,340 base-pair (bp) with a % G+C content of 42.5% (Figure [3](#F3){ref-type="fig"}). Terminal duplications at the extremities of the assembled sequence are 14,373 bp, giving a non-redundant genome of 288,967 bp. Glimmer and Genemark predicted 301 putative ORFs, which comprised 93.8% of the total sequence and were mostly oriented in a single direction. Most ORFs initiate translation at an ATG start codon except for 6 ORFs, 4 of which have a GTG start codon and the other 2 a TTG start codon. We did not find any tRNA in the genome. Of the 301 predicted ORFs, 110 ORFs (36.4%) had significant homologs in public databases and a biochemical function could be assigned for 62 of these (Table [2](#T2){ref-type="table"}, Figure [3](#F3){ref-type="fig"}). Blast searches revealed that most of the ORFs (66/110) with significant homologs were closely related to other *Myovirida*e (Table [2](#T2){ref-type="table"}). Most best-hits corresponded to members of the genus *Phikzvirus*, which comprises myoviruses with a large genome (\> 200 kb), including *Pseudomonas* phages Phikz and PhiPA3*, Erwinia* phage *Ea35-70, Ralstonia* phage RSF1 and RSL2 and *Vibrio* phage pVa21, VP4B, pTD1, Phabio, and Noxifer. Although many gene functions could be assigned, most of the predicted genes are ORFans that are unique to BONAISHI.

###### 

Summary table of *Vibrio* phage BONAISHI predicted proteins that contained relevant annotation information as determined from significant BLASTP hits (*e*-value \< e-3) against the GenBank non-redundant and CAZY databases.

            **Predicted function**                               **START**   **STOP**   **Size (n)**   **Best-hit**                         **Classification**   **E-value**   **Score (bits)**   **N°accession**
  --------- ---------------------------------------------------- ----------- ---------- -------------- ------------------------------------ -------------------- ------------- ------------------ ----------------------------------
  ORF01c    hypothetical protein                                 653         1753       1100           *Pseudocercospora musae*             Fungi                2.00E-07      66.00              [KNG49823.1](KNG49823.1)
  ORF02c    SbcC-like protein                                    1750        2184       435            *Pseudomonas phage 201phi2-1*        Myoviridae           1.00E-17      88.00              [YP_001956973](YP_001956973)
  ORF03     conserved hypothetical protein                       2241        3119       879            *Pseudomonas phage Phikz*            Myoviridae           2.00E-32      130.00             [NP_803730](NP_803730)
  ORF05     PaaR repeat-containing protein                       3722        4018       297            *Vibrio cholerae*                    ⋎-proteobacteria     3.00E-21      89.00              [WP_057643503](WP_057643503)
  ORF06c    conserved hypothetical protein                       4055        4657       603            *Pseudomonas phage Phikz*            Myoviridae           1.00E-25      203.00             [AAL83062](AAL83062)
  ORF07c    virion structural protein                            4667        5962       1296           *Pseudomonas phage KTN4*             Myoviridae           7.00E-32      147.00             [ANM44952.1](ANM44952.1)
  ORF10     ribonuclease H                                       6889        8271       1383           *Pseudomonas phage 201phi2-1*        Myoviridae           3.00E-25      117.00             [YP_001956963](YP_001956963)
  ORF12     *uvsx* protein                                       9269        10744      1476           *Pseudomonas phage 201phi2-1*        Myoviridae           1.00E-89      290.00             [YP_001956960](YP_001956960)
  ORF13     conserved hypothetical protein                       10746       11108      363            *Pseudomonas phage phiPA3*           Myoviridae           3.00E-28      108.00             [AEH03597](AEH03597)
  ORF15     virion structural protein                            11460       12125      666            *Pseudomonas phage phiPA3*           Myoviridae           2.00E-27      113.00             [AEH03595](AEH03595)
  ORF17     hypothetical protein                                 12558       13256      699            *Erwinia phage Ea35-70*              Myoviridae           8.00E-09      64.00              [YP_009004948](YP_009004948)
  ORF22c    conserved hypothetical protein                       16270       18384      2115           *Ralstonia phage RSL2*               Myoviridae           3.00E-74      261.00             [BAQ02568](BAQ02568)
  ORF23c    glycoside hydrolase                                  18393       24110      5718           *Ralstonia phage RP31*               Myoviridae           2.00E-70      277.00             [BAW19303.1](BAW19303.1)
  ORF24     RNA polymerase beta prime subunit                    24183       25850      1668           *Pseudomonas phage OBP*              Myoviridae           1.00E-110     346.00             [YP_004958184](YP_004958184)
  ORF25     RNA polymerase beta subunit                          25847       28741      2895           *Ralstonia phage RSF1*               Myoviridae           1.00E-102     358.00             [BAS04832](BAS04832)
  ORF26     RNA polymerase beta subunit                          29242       30369      1128           *Pseudomonas phage 201phi2-1*        Myoviridae           2.00E-61      223.00             [YP_001956996](YP_001956996)
  ORF29     conserved hypothetical protein                       32135       32860      726            *Pseudomonas phage Noxifer*          Myoviridae           3.00E-21      110.00             [ARV77361.1](ARV77361.1)
  ORF30     virion structural protein                            32871       33641      771            *Ralstonia phage RSF1*               Myoviridae           3.00E-31      124.00             [BAS04828](BAS04828)
  ORF36c    tail tube protein                                    36168       37040      873            *Pseudomonas phage 201phi2-1*        Myoviridae           2.00E-24      108.00             [YP_001956757](YP_001956757)
  ORF37c    tail shealth protein                                 37089       39137      2049           *Erwinia phage Ea35-70*              Myoviridae           2.00E-83      286.00             [YP_009004971](YP_009004971)
  ORF38     hypothetical protein                                 39208       40278      1071           *Erwinia phage Ea35-70*              Myoviridae           3.00E-09      67.00              [YP_009004972](YP_009004972)
  ORF39     virion structural protein                            40288       42819      2532           *Pseudomonas phage 201 phi2-1*       Myoviridae           2.00E-55      226.00             [YP_001956754.1](YP_001956754.1)
  ORF40     virion structural protein                            42831       44483      1653           *Pseudomonas phage 201phi2-1*        Myoviridae           3.00E-27      125.00             [YP_001956753](YP_001956753)
  ORF41     terminase large subunit                              44535       46691      2157           *Pseudomonas phage 201phi2-1*        Myoviridae           1.00E-142     442.00             [YP_001956731](YP_001956731)
  ORF43c    conserved hypothetical protein                       47798       49027      1230           *Pseudomonas phage Noxifer*          Myoviridae           4.00E-37      164.00             [ARV77197.1](ARV77197.1)
  ORF44     HD domain protein                                    49121       49720      600            *Salmonella phage SPN3US*            Myoviridae           3.00E-23      101.00             [AEP84084](AEP84084)
  ORF49c    RNA-binding protein                                  52606       54225      1620           *Actinomyces massiliensis*           Actinobacteria       2.00E-73      251.00             [WP_017194325](WP_017194325)
  ORF58c    conserved hypothetical protein                       58317       59075      759            *Erwinia phage Ea35-70*              Myoviridae           1.00E-22      102.00             [YP_009005001](YP_009005001)
  ORF59     tubulin-like protein                                 59178       60167      990            *Erwinia phage Ea35-70*              Myoviridae           3.00E-21      101.00             [YP_009005002](YP_009005002)
  ORF68     hypothetical protein                                 64017       64424      408            *Ralstonia phage RSL2*               Myoviridae           7.00E-06      52.00              [BAQ02532](BAQ02532)
  ORF69     conserved hypothetical protein                       64596       66782      2187           *Erwinia phage Ea35-70*              Myoviridae           1.00E-105     345.00             [YP_009005012](YP_009005012)
  ORF70c    hypothetical protein                                 66814       67875      1062           *Ralstonia phage RSF1*               Myoviridae           9.00E-08      63.00              [BAS05022](BAS05022)
  ORF71     hypothetical protein                                 68148       70115      1967           *⋎-protebacteria bacterium*          ⋎-proteobacteria     1.00E-15      94.00              [OUV32520.1](OUV32520.1)
  ORF72     RNA polymerase beta prime subunit                    70204       71697      1494           *Erwinia phage Ea35-70*              Myoviridae           3.00E-44      171.00             [YP_009005015](YP_009005015)
  ORF73     conserved hypothetical protein                       71795       72433      639            *Erwinia phage Ea35-70*              Myoviridae           9.00E-15      79.00              [YP_009005021](YP_009005021)
  ORF76     nuclease SbcC subunit                                73326       74498      1173           *Pseudomonas phage PhipA3*           Myoviridae           1.00E-46      172.00             [AEH03486](AEH03486)
  ORF77     conserved hypothetical protein                       74495       75289      795            *Erwinia phage PhiEaH1*              Siphoviridae         9.00E-23      103.00             [YP_009010069](YP_009010069)
  ORF78     hypothetical protein                                 75301       75972      672            *Uncultured bacterium*               Bacteria             2.00E-06      56.00              [EKD22589](EKD22589)
  ORF79     hypothetical protein                                 76106       77656      1551           *Pseudomonas phage phiPA3*           Myoviridae           9.00E-06      59.00              [AEH03489](AEH03489)
  ORF80     conserved hypothetical protein                       77691       79211      1521           *Pseudomonas phage phiPA3*           Myoviridae           1.00E-16      93.00              [AEH03490](AEH03490)
  ORF81     hypothetical protein                                 79251       81056      1806           *Gossypium arboreum*                 Magnoliopsida        1.00E-06      63.00              [KHG21929](KHG21929)
  ORF82c    hypothetical protein                                 81109       81456      348            *Pseudomonas phage PA7*              Myoviridae           5.00E-09      59.00              [AFO71119](AFO71119)
  ORF83     RNA polymerase beta subunit                          81518       83584      2067           *Pseudomonas phage Phabio*           Myoviridae           8.00E-66      260.00             [ARV76743.1](ARV76743.1)
  ORF84     RNA polymerase beta prime subunit                    83584       85557      1974           *Ralstonia phage RSF1*               Myoviridae           1.00E-50      196.00             [BAS05006](BAS05006)
  ORF85     helicase                                             85657       87198      1542           *Pseudomonas phage OBP*              Myoviridae           1.00E-40      176.00             [AEV89521.1](AEV89521.1)
  ORF86     Clp protease subunit                                 87276       87848      573            *Bacillus cereus*                    Bacilli              5.00E-05      52.00              [WP_048520069](WP_048520069)
  ORF87     ATP-dependent Clp protease proteolytic subunit       87848       88339      492            *Dactylosporangium aurantiacum*      Actinobacteria       1.00E-27      110.00             [WP_033356707](WP_033356707)
  ORF89c    conserved hypothetical protein                       88833       90389      1557           *Pseudomonas phage PA7*              Myoviridae           2.00E-15      89.00              [AFO71110](AFO71110)
  ORF92     RNA polymerase beta prime subunit                    91656       92915      1260           *Ralstonia phage RSF1*               Myoviridae           8.00E-49      180.00             [BAS04991](BAS04991)
  ORF96c    DNA polymerase *polB*                                96090       97820      1731           *Ralstonia phape RP12*               Unclassified virus   6.00E-107     343.00             [BAW19225.1](BAW19225.1)
  ORF97     virion structural protein                            97895       99190      1296           *Erwinia phage PhiEaH1*              Siphoviridae         2.00E-23      111.00             [YP_009010288](YP_009010288)
  ORF99c    virion structural protein                            101147      104005     2859           *Pseudomonas phage 201phi2-1*        Myoviridae           1.00E-93      327.00             [YP_001956873](YP_001956873)
  ORF100c   virion structural protein                            104007      105122     1116           *Ralstonia phage RSL2*               Myoviridae           2.00E-49      180.00             [BAQ02702](BAQ02702)
  ORF101    capsid protein\*                                     105166      106242     1077           *Ralstonia phage RSF1*               Myoviridae           3.00E-22      105.00             [BAS04975](BAS04975)
  ORF102    virion structural protein                            106257      107141     885            *Ralstonia phage RSF1*               Myoviridae           4.00E-07      60.00              [BAS04974](BAS04974)
  ORF104    hypothetical protein                                 107713      109107     1394           ⋎-*protebacteria bacterium*          ⋎-proteobacteria     1.00E-12      83.00              [OUV32343.1](OUV32343.1)
  ORF107    conserved hypothetical protein                       111644      113257     1614           *Ralstonia phage RSF1*               Myoviridae           8.00E-22      108.00             [BAS04969](BAS04969)
  ORF108    virion structural protein                            113257      114459     1203           *Pseudomonas phage PhiPA3*           Myoviridae           8.00E-12      77.00              [AEH03528](AEH03528)
  ORF110    virion structural protein                            115149      116531     1383           *Pseudomonas phage PhiPA3*           Myoviridae           2.00E-28      126.00             [AEH03530](AEH03530)
  ORF111c   helicase                                             116571      118181     1611           *Pseudomonas phage 201phi2-1*        Myoviridae           2.00E-48      1884.00            [YP_001956921](YP_001956921)
  ORF113    major capsid protein                                 118843      121035     2193           *Erwinia phage Ea35-70*              Myoviridae           2.00E-23      116.00             [YP_009005109](YP_009005109)
  ORF115    conserved hypothetical protein                       122460      124031     1572           *Ralstonia phage RSL2*               Myoviridae           1.00E-46      179.00             [BAQ02643](BAQ02643)
  ORF118c   holliday-junction resolvase                          127427      127987     561            *Pseudomonas phage Phabio*           Myoviridae           4.00E-18      99.00              [ARV76843.1](ARV76843.1)
  ORF119c   virion structural protein                            128029      128865     837            *Pseudomonas phage 201phi2-1*        Myoviridae           8.00E-44      159.00             [YP_001956947](YP_001956947)
  ORF120c   virion structural protein                            128878      130947     2070           *Pseudomonas phage phiPA3*           Myoviridae           7.00E-72      256.00             [AEH03570](AEH03570)
  ORF121    virion structural protein                            131049      133649     2601           *Pseudomonas phage phabio*           Myoviridae           4.00E-61      245.00             [ARV76832.1](ARV76832.1)
  ORF133    hypothetical protein                                 139060      140100     1041           *Vibrio tasmaniensis*                ⋎-proteobacteria     2.00E-11      73.00              [WP_017112059](WP_017112059)
  ORF138    glycoside hydrolase                                  141805      142716     912            *Aureimonas altamirensis*            α-proteobacteria     2.00E-49      174.00             [BAT26087](BAT26087)
  ORF141    hypothetical protein                                 145070      148201     3132           *Psychromonas ingrahamii*            ⋎-proteobacteria     1.00E-08      72.00              [WP_011768462.1](WP_011768462.1)
  ORF143    hypothetical protein                                 150013      151644     1631           *Vibrio phage s4-7*                  Unclassified virus   2.00E-06      63.00              [AOQ26845.1](AOQ26845.1)
  ORF151    hypothetical protein                                 160192      161433     1242           *Colwellia phage 9A*                 Siphoviridae         4.00E-08      66.00              [YP_006489231](YP_006489231)
  ORF159    hypothetical protein                                 168857      169801     945            *Escherichia phage phAPEC8*          Myoviridae           4.00E-10      68.00              [YP_007348452](YP_007348452)
  ORF163    hypothetical protein                                 172164      172847     684            *Ruegeria halocynthiae*              α-proteobactérie     1.00E-19      91.00              [WP_037312174](WP_037312174)
  ORF167    dead-like helicase                                   176707      178806     2100           *Erwinia phage Ea35-70*              Myoviridae           1.00E-114     367.00             [YP_009004923](YP_009004923)
  ORF172    nicotinamide-nucleotide adenylyltransferase          182827      184476     1650           *Vibrio phage 11895-B1*              Myoviridae           1.00E-106     331.00             [YP_007673553](YP_007673553)
  ORF176    nicotinamide-nucleotide adenylyltransferase          185996      187114     1119           *Thiorhodococcus drewsii*            ⋎-proteobacteria     3.00E-46      170.00             [WP_007039048](WP_007039048)
  ORF177    nicotinamide phosphoribosyltransferase               187169      188668     1500           *Vibrio nigripulchritudo*            ⋎-proteobacteria     3.00E-59      210.00             [WP_022562194](WP_022562194)
  ORF181    nicotinamide riboside transporter                    190786      191502     717            *Vibrio phage 11895-B1*              Myoviridae           3.00E-76      238.00             [YP_007673552](YP_007673552)
  ORF189    hypothetical protein                                 196049      196543     717            *Kaistia granuli*                    α-proteobacteria     1.00E-08      57.00              [WP_018183972](WP_018183972)
  ORF198    NAD-dependent DNA ligase                             204242      206257     2016           *Vibrio maritimus*                   ⋎-proteobacteria     0.00E+00      608.00             [WP_042496716](WP_042496716)
  ORF200    phosphatase                                          206698      207330     633            *Vibrio phage VH7D*                  Myoviridae           6.00E-19      89.00              [YP_009006310](YP_009006310)
  ORF206    hypothetical protein                                 210803      211318     516            *Psychromonas aquimarina*            ⋎-proteobacteria     7.00E-34      126.00             [WP_028862581](WP_028862581)
  ORF209    hypothetical protein                                 213895      214209     315            *Enterovibrio calviensis*            ⋎-proteobacteria     6.00E-07      52.00              [WP_017007757](WP_017007757)
  ORF212    transcriptional regulator                            215240      215764     525            *Leptolyngbya sp. PCC 7375*          cyanobacteria        1.00E-05      53.00              [EKV01169](EKV01169)
  ORF220    hypothetical protein                                 220875      221303     429            *Shewanella sp. phage 1/4*           Myoviridae           6.00E-11      64.00              [YP_009100318](YP_009100318)
  ORF227    hypothetical protein                                 224066      224998     933            *Pseudomonas phage PhiPA3*           Myoviridae           9.00E-06      57.00              [AEH03433](AEH03433)
  ORF229    hypothetical protein                                 226086      227921     1835           *Vibrio phage RYC*                   Unclassified virus   7.00E-70      243.00             [BAV81012.1](BAV81012.1)
  ORF231    thymidylate kinase                                   228796      229458     663            *Desulfosporosinus acidiphilus*      Clostridia           8.00E-42      150.00             [WP_014828008](WP_014828008)
  ORF232    ribonucleotide-diphosphate reductase subunit alpha   229535      230446     912            *Aeromonas molluscorum 848*          ⋎-proteobacteria     1.00E-132     385.00             [EOD53957](EOD53957)
  ORF233    ribonucleotide-diphosphate reductase subunit alpha   230844      232277     1434           *Neisseria meningitidis*             β-proteobacteria     0.00E+00      635.00             [WP_049227356](WP_049227356)
  ORF234    ribonucleotide-diphosphate reductase subunit beta    232355      233062     708            *Thiomicrospira sp. Kp2*             ⋎-proteobacteria     3.00E-96      294.00             [WP_040727751](WP_040727751)
  ORF235    HNH endonuclease                                     233205      233927     723            *Bacillus pumilus*                   Bacilli              7.00E-32      123.00             [WP_051149989](WP_051149989)
  ORF236    ribonucleotide-diphosphate reductase subunit beta    234231      234617     387            *Shigella sonnei*                    ⋎-proteobacteria     2.00E-36      129.00             [CSE34793](CSE34793)
  ORF238    hypothetical protein                                 235508      237232     1725           *Polyangium brachysporum*            β-proteobacteria     2.00E-23      114.00             [WP_047195109](WP_047195109)
  ORF249c   hypothetical protein                                 242652      244886     2235           *Vibrio mimicus*                     ⋎-proteobacteria     4.00E-08      67.00              [WP_001015571](WP_001015571)
  ORF253    phosphatase                                          246359      247015     657            *Verrucomicrobium spinosum*          verucomicrobia       2.00E-22      97.00              [WP_009962909](WP_009962909)
  ORF254    hypothetical protein                                 247012      247842     831            *Shewanella sp*.                     ⋎-proteobacteria     6.00E-06      57.00              [WP101034114.1](WP101034114.1)
  ORF255    ATP-binding protein                                  247870      248553     684            *Vibrio phage RYC*                   Unclassified virus   1.00E-36      137.00             [BAV81012.1](BAV81012.1)
  ORF256c   T5 A1-like protein                                   248608      250479     1872           *Caulobacter phage phiCbK*           Siphoviridae         3.00E-83      281.00             [YP_006988022](YP_006988022)
  ORF257c   hypothetical protein                                 250484      250927     444            *Pseudoalteromonas (multispecies)*   ⋎-proteobacteria     9.00E-19      86.00              [WP_024591352](WP_024591352)
  ORF258    conserved hypothetical protein                       251087      252592     1506           *Campylobacter phage CP30A*          Myoviridae           3.00E-20      102.00             [YP_006908082](YP_006908082)
  ORF259    conserved hypothetical protein                       252655      253968     1314           *Campylobacter phage CP30A*          Myoviridae           2.00E-18      96.00              [YP_006908082](YP_006908082)
  ORF261    phosphate starvation protein PhoH                    254632      255627     996            *Corynebacterium glucuronolyticum*   Actinobacteria       6.00E-49      175.00             [WP_005389286](WP_005389286)
  ORF269    thymidylate synthase-complementing protein           260653      262095     1443           *Parcubacteria*                      Parcubacteria        5.00E-62      217.00             [KKR42866](KKR42866)
  ORF272    conserved hypothetical protein                       263205      263723     519            *Cronobacter phage vB_CsaM_GAP32*    Myoviridae           9.00E-15      77.00              [YP_006987447](YP_006987447)
  ORF289    conserved hypothetical protein                       273177      273917     740            *Vibrio phage vB_VhaS-a*             Unclassified virus   4.00E-18      100.00             [ANO57550.1](ANO57550.1)
  ORF290    conserved hypothetical protein                       273997      274665     668            *Vibrio phage vB_VhaS-a*             Unclassified virus   1.00E-14      88.00              [ANO57549.1](ANO57549.1)
  ORF295c   hypothetical protein                                 276639      277370     731            *Ralstonia phage RP12*               Myoviridae           9.00E-10      73.00              [BAW19047.1](BAW19047.1)
  ORF300    hypothetical tail protein                            286648      287631     983            *Pseudomonas phage Phabio*           Myoviridae           7.00E-15      90.00              [ARV76834.1](ARV76834.1)
  ORF301    virion structural protein                            287726      288967     1241           *Pseudomonas phage Noxifer*          Myoviridae           3.00E-07      65.00              [ARV77324.1](ARV77324.1)

![Genome map of BONAISHI. The 110 protein-coding genes are shown as colored blocks. Protein-coding genes that are transcribed in the forward and reverse direction are located on the external and internal circle, respectively. The functional assignments of the protein-coding genes are derived from blastp matches in NCBI nr and expert databases. We confidently discriminated proteins involved in general virion structure (light blue), head, and tail structure and assembly (dark blue), DNA replication,recombination and repair (red), nucleotide metabolism (orange), DNA transcription (pink), and host phage interactions (green). Genes marked "h.p." made strong matches to hypothetical protein sequences in the database with no identified functions (dark gray). The GC content of the genome sequence is indicated by the internal purple or green histograms.](fmicb-09-02501-g0003){#F3}

Gene annotation
---------------

### Proteins involved in virion structure and assembly

The predicted proteins involved in the virion structure and assembly included a major and an accessory capsid protein (ORF 101 and 113), several tail components including a tail tube (ORF 36), a tail shealth (ORF 37), and an accessory tail protein (ORF 300), as well as several conserved structural proteins (ORFs 7, 15, 30, 39, 40, 97, 99, 100, 102, 108, 110, 119, 120, 121, and 301). We also identified a terminase large subunit (ORF 41) involved in DNA packaging. All these structural components shared strong homologies with proteins encoded by other members of *Phikzvirus* genus (Table [1](#T1){ref-type="table"}, Figure [S1](#SM1){ref-type="supplementary-material"}). Phylogenetic analyses based on the amino acid sequence of the terminase large subunit classified BONAISHI as a singleton (Figure [4](#F4){ref-type="fig"}). The closest sequences belong to *Vibrio* phage pVa-21 and a cluster with *Cronobacter* phage CR5, *Erwinia* phage vB EamM, phiEaH2 and *Salmonella* phage SPN3US. The second closest cluster comprised *Phikzvirus Pseudomonas* phage KTN4, Phikz, Noxifer, PA3, Phabio, and 201 phi2-1.

![Phylogenetic analysis of 63 Jumbo phages based on the amino acids sequence of the terminase large subunit. Sequences were aligned by Muscle and the tree was constructed by Maximum Likelihood method with a bootstrap of 1,000 using Mega 6.0 (Tamura et al., [@B59]) as in Yuan and Gao ([@B67]). Bootstrap values higher than 0.5 are represented by black circles, ranging from 0.5 (smaller circle) to 1 (bigger circle).](fmicb-09-02501-g0004){#F4}

### Proteins involved in dna replication, recombination and repair

The BONAISHI genome encoded at least 10 proteins involved in DNA replication, recombination, and repair. These included a DNA polymerase B (ORF 96), putative DnaB, and DEAD-like helicases (ORF 85 and 111), NAD-dependent DNA ligase (ORF 198), SbcC-like nucleases (ORF2 and 76), a ribonuclease H (ORF 10), Holliday junction resolvase (ORF 118), uvsx recombinase (ORF12). ORF 235 corresponded to the HNH family of homing endonuclease located between genes encoding β subunits of ribonucleotide diphosphate reductase.

### Proteins involved in nucleotide metabolism and dna modification

We were able to assign a putative function to 10 enzymes involved into nucleotide metabolism. Predicted proteins included two ribonucleotide diphosphate reductase (RDR) α subunits (ORFs 232 and 233) and two RDR β subunits (ORFs 234 and 236), 4 proteins of the pyridine nucleotide salvage pathway corresponding to a nicotinamide riboside transporter (ORF 181), a nicotinamide phosphoribosyltransferase (ORF 177) as well as nicotinamide mononucleotide adenylyltransferases (ORF 172 and 176). BONAISHI also encodes 2 proteins involved in thymidine biosynthesis one of which is a thymidylate synthase complementing protein (ORF 269) and the other a thymidylate kinase (ORF 231). We did not identify any gene for protein involved in DNA modification.

### Proteins involved in dna transcription

A transcription regulator related to the PadR family (ORF 212) was found as well as two sets of multisubunit RNA polymerase genes (β- and β\'- RNAP subunits). ORFs 24, 25, 26, 92 corresponded to the Phikz virion-associated RNAP and ORFs 72, 83, 84 shared significant homologies with the Phikz genes encoding the early expressed RNAP (Table [2](#T2){ref-type="table"}, Figure [S1](#SM1){ref-type="supplementary-material"}). No homologs of the early expressed Phikz β- RNAP subunits were found in BONAISHI genome. ORF 49 was assigned to an RNA binding protein.

### Lysis, host-phage interaction, and lysogeny

We were able to annotate two proteins (ORFs 23 and 138) involved into host-virus interactions. There were good blastp hits on proteins of unknown function in the NCBI nr database that could be expanded to known glycoside hydrolases (GH) in the expert database CAZY (Carbohydrate Active enZYmes db, <http://www.cazy.org>). These included a glycoside hydrolase with a conserved endopeptidase domain (ORF 23) affiliated to the GH23 family, which mostly include lysozymes. The protein encoded by ORF 138 belongs to the glycoside hydrolase family GH19, which comprises chitinases and lysozymes. Both enzyme groups catalyze the hydrolysis of polysaccharides containing N-Acetylglucosamine, but the gene sequence does not discriminate between the two. No genes implicated in lysogeny establishment or control (integrase/excisionase, transposases, ParA/ParB genes, attachment sites, transcription repressor, etc.) were detected in the BONAISHI genome, even using prophage expert databases, which confirms that it is exclusively lytic. In addition, blastp searches using BONAISHI hosts genome did not find evidence of the presence of BONAISHI as prophage. Only three genes involved in DNA replication and recombination (ORF 225), nucleotide metabolism (ORF 192) and gene encoding for a phosphate starvation protein showed high score but the similarity was relatively low (\<77%).

### Miscellaneous proteins

We identified a phosphate starvation protein PhoH (ORF 261). This protein has been reported in many other *Myoviridae*. For therapeutic applications of this phage, we also looked for potential toxin encoding genes using BLASTP on 4 toxin expert databases. No homologs to currently known toxins were detected.

### Metagenomic analysis

The global distribution of BONAISHI was investigated using marine viromes from various waters including coral mucus and the water from coral reefs (Table [S2](#SM2){ref-type="supplementary-material"}). The highest number of recruited reads was from the virome collected at ALOHA station in the North Pacific subtropical gyre (CAM_SMPL_00823): BONAISHI recruited 1.04% of the reads with a mean identity of 58.23%. None of the recruited reads exceeded 85% identity. We also used prokaryotic metagenomes to test whether the BONAISHI genome is found as a prophage in bacterial hosts. No bacterial reads were recruited.

Preliminary therapy assays of diseased symbiodinium
---------------------------------------------------

*Symbiodinium* sp. control culture showed optimal photosynthetic activity with the quantum yield Fv/Fm between 0.57 and 0.59 during the course of the experiment. As expected, inoculation with *V. coralliilyticus* caused a rapid photoinhibition with a 50% decrease in the quantum yield 60 min after inoculation (Figure [5](#F5){ref-type="fig"}). BONAISHI was able to significantly counteract the bacterial algicidal activity (*t*-test, *p* \< 0.001) as, with both *V. coralliilyticus* and BONAISHI, the quantum yield was only 14% lower than the control 60 min after inoculation.

![Quantum yield (Fv/Fm) of the photosystem II of control *Symbiodinium* sp. culture (black), *Symbiodinium* sp. inoculated with *V. coralliilyticus* YB1 pathogen (gray), and *Symbiodinium* sp. co-inoculated with *V. coralliilyticus* YB1 pathogen and *Vibrio* phage BONAISHI (hashed) after 60 min incubation. Results are expressed as the % of Fv/Fm in the control culture. As reported in previous study, the inoculation of *V. coralliilyticus* YB1 pathogen induced a rapid decline in *Symbiodinium* sp. photochemical efficiency. The addition of BONAISHI rapidly counteracted the impact of *V. coralliilyticus* YB1 on the efficiency of *Symbiodinium* photochemical activity.](fmicb-09-02501-g0005){#F5}

Discussion {#s4}
==========

In recent years, *Vibrio coralliilyticus* has been used as a model pathogen to gain insights into the establishement and propagation of coral diseases (Sussman et al., [@B58]; O\'Santos et al., [@B48]; Garren et al., [@B27]; Pollock et al., [@B51]). The use of phages to control *V. coralliilyticus* has been reported recently (Efrony et al., [@B25]; Cohen et al., [@B15]) but if phage therapy is to become a practical approach, fundamental knowledge on pathogen-virus interactions must be investigated in detail to evaluate, on the one hand, the therapeutic potential of the candidate phage and, on the other hand, the suitability of the host for phage therapy.

The detection of virus-derived genes in the *Vibrio coralliilyticus* P1 and YB1 genomes (Weynberg et al., [@B62]) shows that these pathogenic strains have interacted with phages during the course of their evolutionary history. Past interactions events with viruses can lead to the development of resistance mechanisms to escape phage infection, which may, in turn, limit the application of phage therapy. We, however, did not detect any of the distinctive genetic signatures of viral resistance mechanisms, such as the insertion of short palindromic sequences (CRISPR, data not shown) in *V. coralliilyticus* P1 and YB1. Although other resistance mechanisms exist, the recurrent isolation of phages that infect *V. coralliilyticus* YB1 and/or P1 (Efrony et al., [@B25]; Cohen et al., [@B15]; Ramphul et al., [@B52]) supports the idea that *V. coralliilyticus* pathogens are permissive to viral infection and are suitable candidates for treatment by phage therapy.

The *Vibrio* phage BONAISHI isolated from coastal waters in the South China Sea is distinct from the known *V. coralliiltyicus* phages YB2, YC, CKB-S1, CKB-S2, RYC (Efrony et al., [@B25]; Cohen et al., [@B15]; Ramphul et al., [@B52]). Although all these phages belong to the order of *Caudovirales* (tailed bacteriophages), BONAISHI has an unusually large genome, 303 kbp, rather than 11 kbp to 158 kbp. With such a large genome, BONAISHI is a novel jumbo phage (or giant phage). These are tailed phages with a dsDNA genome larger than 200 kb (Hendrix, [@B32]; Yuan and Gao, [@B67]). Jumbo phages have often been isolated in recent years and they mostly infect Gram-negative bacteria, including the genera *Synechoccocus, Vibrio, Pseudomonas, Caulobacter, Erwinia*, and *Aeromonas* (Yuan and Gao, [@B67]). As observed for most jumbo phages, the large genome of BONAISHI is packaged in a large head connected to a long, contractile tail. The genome of jumbo phages typically includes core genes involved in virion structure and assembly, DNA replication, and nucleotide metabolism, including several genes encoding multisubunit RNAP. In BONAISHI, the core genes are scattered throughout the genome sequence and most of them share significant homology with other jumbo phages affiliated to the *Phikzvirus* genus. BONAISHI is the first marine representative of this divergent group within the *Myoviridae*. Interestingly, many Phikzviruses are considered to be promising biocontrol agents for plant-pathogenic bacteria (*Ralstonia solanacearum, Erwinia amylovora*) and some of them are already found in commercial products for phage therapy (Fujiwara et al., [@B26]; Bhunchoth et al., [@B7]).

The life history traits and genomic analysis showed that *Vibrio* phage BONAISHI is a good candidate for biological control of *V. coralliilyticus*. Firstly, BONAISHI appears to be structurally stable as it can withstand a wider range of pH (3--10) and temperature (4--45°C) than in the environment where it would be used. Second, it readily infects and lyses several pathogenic strains of *V. coralliilyticus* but no related species. Thirdly incubation experiments showed that the replication cycle is fast (latent period \< 3 h). The presence of genes encoding virion-associated RNAP (ORFs 24, 25, 26, and 92) and early-expressed RNAP (ORFs 72, 83, and 84) in the BONAISHI genome may, at least partly, explain the rapid cycle (Ceyssens et al., [@B11]). In Phikzviruses, these two sets of RNAP may operate in concert during the replication cycle (Ceyssens et al., [@B11]; Yuan and Gao, [@B67]). The virion-associated RNAP may be injected into the host cell to start immediate gene expression whereas the early expressed RNAP may function during the middle and late phases of phage gene expression. The consecutive action of these enzymes, unique to Phikzviruses, confers the ability to produce viral progeny independently of the host transcription apparatus (Ceyssens et al., [@B11]; Yuan and Gao, [@B67]). In addition, the absence of detectable tRNA in BONAISHI genome suggests that it is well adapted to the translation machinery of its hosts, which is a critical process for efficient phage propagation. Finally, the genomic analysis did not identify any temperate phage hallmarks such as integration mediating enzymes, or genome architecture or sequence similarity with known temperate phages. Furthermore, the absence of homology between BONAISHI gene sequences and bacteria reads from coral metagenomes supports the idea that this phage does not integrate into the host genome. These results suggest very strongly that the *Vibrio* phage BONAISHI is a strictly lytic phage that is species specific and stable, although it appears to be relatively rare in the environment.

Another important issue for therapeutic applications of phages is to ensure that the candidate does not perform specialized or generalized transduction (Duckworth and Gulig, [@B23]). Given that BONAISHI appears to be strictly lytic based on the growth experiments and the genome analysis, it is unlikely that this candidate will perform specialized transduction of host DNA. Specialized transduction is restricted to temperate phages and occurs when the prophage is not cleanly excised during induction and includes the flanking bacterial genes which are then packaged in the viral progeny. Our candidate, however, may be able to perform generalized transduction. In this type of transduction, random segments of degraded host chromosome are mistakenly packaged instead of the phage DNA and may be transmitted by horizontal gene transfer. Phages that use a headful DNA packaging mechanism, such as many jumbo phages including BONAISHI, may be able to perform generalized transduction. However, it is, to the best of our knowledge, impossible to predict the frequency of generalized transduction based purely on the genome analysis. For example, giant bacteriophages with similar headful DNA packaging mechanisms can have very different transduction rates as, for example, the T4 and T4G bacteriophages (Young et al., [@B66]; Young and Edlin, [@B65]). The ability of BONAISHI to perform generalized transduction would, therefore, require proper laboratory investigation.

An alternative to avoid potential issue with phage-mediated gene transfer is, rather than using whole bacetriophages, to use bacteriolytic proteins encoded by phages, among which the most notable are phage-encoded peptidoglycan hydrolases (PGH, see review by Roach and Debarbieux, [@B53]). PGHs, also called endolysins, degrade the cell peptidoglycan from within and contribute to the release of progeny and cell burst. A second type of PGH can be associated with the virion and initiate cell wall penetration through localized peptidoglycan or lipopolysaccharide degradation during the infection process. Both types of PGH are already used as bacteriocins in animal models of human infection and disease (see Roach and Debarbieux, [@B53] and references therein). Jumbo phages typically encode more proteins for the lysis of the host cell wall including endolysin, glycoside hydrolase and chitinase, which are often bound to the virion than small genome phages (Yuan and Gao, [@B67]). In BONAISHI genome, we identified two glycoside hydrolases distantly related to known enzymes that belong to the families GH19 and GH23 using the expert database CAZY. Although the catalytic activities of these molecules cannot be determined based solely on the genome analysis, their overexpression and characterization might provide interesting tools for controlling *V. coralliilyticus* infection.

A preliminary assay suggests that BONAISHI is a promising candidate for treating *V. coralliilyticus* infection. Studies investigating the action of *V. coralliilyticus* on coral symbionts showed that photosynthesis was inactivated by the expression of a Zn-metalloprotease (Sussman et al., [@B57]). Our experiments on *Symbiodinum* cultures infected by *V. coralliilyticus* showed that BONAISHI phage treatment was effective: adding the phage to the infected cultures rapidly reduced *Symbiodinium* PSII inactivation. As reported in previous studies, phage addition probably lysed the bacterial pathogen, stopping Zn-metalloprotease production and further damage to *Symbiodinium* sp. cells (Cohen et al., [@B15]). Future studies should now focus on the effectiveness of the treatment either under realistic field conditions or in mesocosms to start including bacteriophages (and/or derived compounds) in an integrated management program to mitigate the damage caused by the infectious agents responsible for coral diseases. We recommend genome sequencing and analysis of any future phage candidate as a prerequisite to any field test to ensure safe environmental applications as this provides essential information on the phage replication cycle and host-virus interactions.
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